Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Environ Sci Pollut Res Int ; 29(1): 779-789, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-34341928

RESUMEN

Nonalcoholic fatty liver disease is a hepatic disorder with deposition of fat droplets and has a high risk of progression to steatosis-related hepatitis and irreversible hepatic cancer. Metronidazole (MNZ) is an antiprotozoal and antimicrobial agent widely used to treat patients infected with anaerobic bacteria and intestinal parasites; however, MNZ has also been shown to induce liver tumors in rodents. To investigate the effects of MNZ on steatosis-related early-stage hepatocarcinogenesis, male rats treated with N-nitrosodiethylamine following 2/3 hepatectomy at week 3 were received a control basal diet, high fat diet (HFD), or HFD containing 0.5% MNZ. The HFD induced obesity and steatosis in the liver, accompanied by altered expression of Pparg and Fasn, genes related to lipid metabolism. MNZ increased nuclear translocation of lipid metabolism-related transcription factor peroxisome proliferator-activated receptor gamma in hepatocytes, together with altered liver expression of lipid metabolism genes (Srebf1, Srebf2, Pnpla2). Furthermore, MNZ significantly increased the number of preneoplastic liver foci, accompanied by DNA double-strand breaks and late-stage autophagy inhibition, as reflected by increased levels of γ-H2AX, LC3, and p62. Therefore, MNZ could induce steatosis-related hepatocarcinogenesis by inducing DNA double-strand breaks and modulating autophagy in HFD-fed rats.


Asunto(s)
Dieta Alta en Grasa , Enfermedad del Hígado Graso no Alcohólico , Animales , Autofagia , ADN/metabolismo , Dieta Alta en Grasa/efectos adversos , Humanos , Metabolismo de los Lípidos , Hígado/metabolismo , Masculino , Metronidazol , Ratones , Ratones Endogámicos C57BL , Enfermedad del Hígado Graso no Alcohólico/metabolismo , Ratas
2.
J Toxicol Sci ; 43(10): 611-621, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30298849

RESUMEN

Mineralocorticoid receptor (MR)/NADPH oxidase (NOX) signaling is involved in the development of obesity, insulin resistance, and renal diseases; however, the role of this signaling on steatotic preneoplastic liver lesions is not fully elucidated. We determined the effects of the MR antagonist potassium canrenoate (PC) on MR/NOX signaling in hepatic steatosis and preneoplastic glutathione S-transferase placental form (GST-P)-positive liver foci. Rats were subjected to a two-stage hepatocarcinogenesis model and fed with basal diet or high fat diet (HFD) that was co-administered with PC alone or in combination with the antioxidant alpha-glycosyl isoquercitrin (AGIQ). PC reduced obesity and renal changes (basophilic tubules that expressed MR and p22phox) but did not affect blood glucose tolerance and non-alcoholic fatty liver disease activity score (NAS) in HFD-fed rats. However, the drug increased the area of GST-P-positive liver foci that expressed MR and p22phox as well as increased expression of NOX genes (p22phox, Poldip2, and NOX4). PC in combination with AGIQ had the potential of inhibiting the effects of PC on the area of GST-P-positive liver foci and the effects were associated with increasing expression of an anti-oxidative enzyme (Catalase). The results suggested that MR/NOX signaling might be involved in development of preneoplastic liver foci and renal basophilic changes in HFD-fed rats; however, the impacts of PC were different in each organ.


Asunto(s)
Ácido Canrenoico/farmacología , Dieta Alta en Grasa/efectos adversos , Riñón/patología , Neoplasias Hepáticas/etiología , Neoplasias Hepáticas/patología , Hígado/patología , Antagonistas de Receptores de Mineralocorticoides/farmacología , Animales , Antioxidantes/administración & dosificación , Antioxidantes/farmacología , Ácido Canrenoico/administración & dosificación , Catalasa/metabolismo , Modelos Animales de Enfermedad , Expresión Génica , Gutatión-S-Transferasa pi/metabolismo , Riñón/metabolismo , Hígado/metabolismo , Antagonistas de Receptores de Mineralocorticoides/administración & dosificación , NADPH Oxidasas/genética , NADPH Oxidasas/metabolismo , NADPH Oxidasas/fisiología , Especificidad de Órganos , Quercetina/administración & dosificación , Quercetina/análogos & derivados , Quercetina/farmacología , Receptores de Mineralocorticoides/metabolismo , Receptores de Mineralocorticoides/fisiología , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología
3.
Toxicol Pathol ; 46(5): 530-539, 2018 07.
Artículo en Inglés | MEDLINE | ID: mdl-29843569

RESUMEN

Administration of the diuretic, spironolactone (SR), can inhibit chronic liver diseases. We determined the effects of SR alone or in combination with the antioxidant α-glycosyl isoquercitrin (AGIQ) on hyperlipidemia- and steatosis-related precancerous lesions in high-fat diet (HFD)-fed rats subjected to a two-stage hepatocarcinogenesis model. Rats were fed with control basal diet or HFD, which was administered with SR alone or in combination with an antioxidant AGIQ in drinking water. An HFD increased body weight, intra-abdominal fat (adipose) tissue weight, and plasma lipids, which were reduced by coadministration of SR and AGIQ. SR and AGIQ coadministration also reduced hepatic steatosis and preneoplastic glutathione S-transferase placental form-positive foci, in association with decrease in NADPH oxidase (NOX) subunit p22phox-positive cells and an increase in active-caspase-3-positive cells in the foci. Hepatic gene expression analysis revealed that the coadministration of SR and AGIQ altered mRNA levels of lipogenic enzymes ( Scd1 and Fasn), antioxidant-related enzymes ( Catalase), NOX component ( P67phox), and anti-inflammatory transcriptional factor ( Pparg). Our results indicated that SR in combination with AGIQ had the potential of suppressing hyperlipidemia- and steatosis-related early hepatocarcinogenesis through the reduced expression of NOX subunits.


Asunto(s)
Dieta Alta en Grasa , Hígado Graso/tratamiento farmacológico , Neoplasias Hepáticas Experimentales/prevención & control , NADPH Oxidasas/metabolismo , Lesiones Precancerosas/prevención & control , Quercetina/análogos & derivados , Espironolactona/uso terapéutico , Animales , Peso Corporal/efectos de los fármacos , Quimioterapia Combinada , Hígado Graso/complicaciones , Hígado Graso/patología , Neoplasias Hepáticas Experimentales/etiología , Neoplasias Hepáticas Experimentales/patología , Masculino , Tamaño de los Órganos/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Lesiones Precancerosas/patología , Quercetina/administración & dosificación , Quercetina/uso terapéutico , Ratas Endogámicas F344 , Espironolactona/administración & dosificación
4.
J Vet Med Sci ; 79(9): 1489-1493, 2017 Sep 12.
Artículo en Inglés | MEDLINE | ID: mdl-28781295

RESUMEN

A 9-year-old, spayed female Chihuahua was presented with a 1-week history of lethargy and anorexia. Abdominal ultrasonography and computed tomography found bilateral adrenal masses without metastasis. Serum cortisol levels that were sampled before and after an adrenocorticotropic hormone stimulation test were within reference ranges. Lethargy and anorexia completely resolved after short-term fluid therapy; the clinical signs did not occur for approximately 8 months until her sudden death. A postmortem examination revealed bilateral adrenocortical carcinomas and liver metastasis. Primary adrenocortical carcinomas developed in the dog met the definition of bilateral incidental adrenal gland masses (IAGMs). This is the first case report to demonstrate based on histological identification that adrenocortical carcinomas cause bilateral IAGMs in dogs.


Asunto(s)
Neoplasias de la Corteza Suprarrenal/veterinaria , Carcinoma Corticosuprarrenal/veterinaria , Enfermedades de los Perros/diagnóstico , Neoplasias de la Corteza Suprarrenal/diagnóstico por imagen , Carcinoma Corticosuprarrenal/diagnóstico por imagen , Carcinoma Corticosuprarrenal/secundario , Amlodipino/uso terapéutico , Animales , Enfermedades de los Perros/diagnóstico por imagen , Perros , Femenino , Neoplasias Hepáticas/secundario , Neoplasias Hepáticas/veterinaria , Piridazinas/uso terapéutico , Tomografía Computarizada por Rayos X/veterinaria , Resultado del Tratamiento , Ultrasonografía/veterinaria
5.
Exp Toxicol Pathol ; 69(7): 517-526, 2017 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-28495474

RESUMEN

Developmental exposure to glycidol of rats causes axonal injury targeting axon terminals in dams and transient disruption of late-stage differentiation of hippocampal neurogenesis, accompanying sustained increase in the number of reelin-producing or calretinin-expressing interneurons in offspring. The molecular mechanism of disruptive neurogenesis probably targets the newly generating nerve terminals. We previously found differences between mice and rats in the effects on hippocampal neurogenesis after developmental exposure to the same neurotoxic substances. In the present study, we examined the effects and underlying mechanisms of developmental exposure to glycidol on hippocampal neurogenesis in mice. Glycidol (800 or 1600ppm) was administered in drinking water to mated female mice from gestational day 6 to postnatal day 21. Compared to mice drinking water without glycidol (control), the exposed dams showed axon terminal injury at both concentrations of glycidol. The offspring of the dams that had received 1600ppm glycidol had fewer parvalbumin (PVALB)+ γ-aminobutyric acid (GABA)-ergic interneurons and neuron-specific nuclear protein+ postmitotic neurons in the hilus of the hippocampal dentate gyrus. Thus, exposure of glycidol to adult mice induced axonal degeneration equivalent to that seen in the rat; however, the target mechanism for the disruption of hippocampal neurogenesis by developmental exposure was different from that in rats, with the hilar neuronal population not affected until adulthood. Considering the role of PVALB+ GABAergic interneurons in the brain, developmental glycidol exposure in mice may cause a decline in cognitive function in later life, and involve a different mechanism from that targeting axon terminals in rats.


Asunto(s)
Compuestos Epoxi/toxicidad , Hipocampo/efectos de los fármacos , Interneuronas/efectos de los fármacos , Neurogénesis/efectos de los fármacos , Efectos Tardíos de la Exposición Prenatal/patología , Propanoles/toxicidad , Animales , Femenino , Hipocampo/patología , Interneuronas/patología , Ratones , Degeneración Nerviosa/inducido químicamente , Degeneración Nerviosa/patología , Parvalbúminas , Embarazo , Proteína Reelina
6.
J Vet Med Sci ; 79(6): 1091-1095, 2017 Jun 29.
Artículo en Inglés | MEDLINE | ID: mdl-28529267

RESUMEN

An 11-year-old female goat had invasive and metastatic endometrial adenocarcinoma in the uterus. There was a notable proliferation of endometrial epithelial cells in a tubular growth pattern, with a desmoplastic response. The endometrial epithelial tumor cells metastasized to the kidney, liver and lung. In contrast to the primary and metastatic tumor cells, pleomorphic tumor cells with a choriocarcinoma-like growth pattern infiltrated the mesometrium. Cell proliferation activity was high in both types of tumor cells. Both types of tumor cells expressed cytokeratins AE1/AE3, 7 and CAM5.2; choriocarcinomatous cells also had positive immunoreactions to human chorionic gonadotropin, human placental alkaline phosphatase and α-inhibin. The present case was diagnosed as endometrial adenocarcinoma with choriocarcinomatous differentiation.


Asunto(s)
Adenocarcinoma/veterinaria , Coriocarcinoma/veterinaria , Neoplasias Endometriales/veterinaria , Enfermedades de las Cabras/patología , Neoplasias Uterinas/veterinaria , Adenocarcinoma/patología , Animales , Coriocarcinoma/patología , Neoplasias Endometriales/patología , Femenino , Enfermedades de las Cabras/diagnóstico , Cabras , Neoplasias Uterinas/patología
7.
J Vet Med Sci ; 79(3): 588-592, 2017 Mar 23.
Artículo en Inglés | MEDLINE | ID: mdl-28190820

RESUMEN

A 17-year-old female wolf (Canis lupus lupus) had a right lung mass that was adhered to the thoracic cavity. Histopathological examination revealed that the mass consisted of sheets, cord or ribbon-like structures of monotonous, small, cuboidal cells with round, oval or short-spindle nuclei and scant clear cytoplasm, demarcated by a fine fibrovascular stroma. Focal necrosis, congestion and thrombi were observed. Immunohistochemically, the tumor cells diffusely expressed cytokeratin AE1/AE3, and some expressed chromogranin A, neural cell adhesion molecule (CD56) and thyroid transcription factor-1. The number of proliferating cell nuclear antigen-positive tumor cells was low. A diagnosis of pulmonary neuroendocrine tumor was based on the resemblance to carcinoids.


Asunto(s)
Neoplasias Pulmonares/veterinaria , Tumores Neuroendocrinos/veterinaria , Lobos , Animales , Animales de Zoológico , Femenino , Neoplasias Pulmonares/patología , Tumores Neuroendocrinos/patología
8.
Exp Toxicol Pathol ; 69(1): 9-16, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27789131

RESUMEN

We determined effects of the NADPH oxidase (NOX) inhibitor apocynin (APO) or the antioxidant enzymatically modified isoquercitrin (EMIQ) on an early stage of hepatocarcinogenesis in the liver with steatosis. Male rats were given a single intraperitoneal injection of N-diethylnitrosamine (DEN) and fed a high-fat diet (HFD) to subject to a two-stage hepatocarcinogenesis model. Two weeks later, rats were fed a HFD containing the lipogenic substance malachite green (MG), which were co-administered with EMIQ or APO in drinking water for 6 weeks. Three after DEN initiation, rats were subjected to a two-third partial hepatectomy to enhance cell proliferation. The HFD increased total cholesterol and alkaline phosphatase levels, which were reduced by EMIQ co-administration. APO co-administration reduced MG-increased preneoplastic liver lesions, glutathione S-transferase placental form (GST-P)-positive, adipophilin-negative liver foci, and tended to decrease MG-increased Ki-67-positive or active caspase-3-positive cells in the liver foci. EMIQ or APO co-administration reduced the expression of a NOX subunit p22phox in the liver foci, but did not alter the numbers of LC3a-positive cells, an autophagy marker. We identified no treatment-related effects on p47phox and NOX4 expression in the liver foci. The results indicated that APO or EMIQ had the potential to suppress hyperlipidaemia and steatosis-preneoplastic liver lesions, through suppression of NOX subunit expression in rats.


Asunto(s)
Acetofenonas/farmacología , Inhibidores Enzimáticos/farmacología , Hígado Graso/enzimología , NADPH Oxidasas/biosíntesis , Quercetina/análogos & derivados , Animales , Carcinogénesis/inducido químicamente , Modelos Animales de Enfermedad , Hígado Graso/patología , Inmunohistoquímica , Hígado/efectos de los fármacos , Hígado/enzimología , Neoplasias Hepáticas Experimentales/inducido químicamente , Neoplasias Hepáticas Experimentales/metabolismo , Masculino , Lesiones Precancerosas/metabolismo , Lesiones Precancerosas/patología , Quercetina/farmacología , Ratas , Ratas Endogámicas F344
9.
J Vet Diagn Invest ; 28(6): 722-728, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27698175

RESUMEN

Two solitary and minute tumors of 1 and 1.5 mm diameter were identified by microscopy in the left fourth mammary gland of a 13-year-old female Labrador Retriever dog, in addition to multiple mammary gland tumors. The former tumors were well circumscribed and were composed of small-to-large polyhedral neoplastic oncocytes with finely granular eosinophilic cytoplasm, and were arranged in solid nests separated by fine fibrovascular septa. Scattered lumina of variable sizes containing eosinophilic secretory material were evident. Cellular atypia was minimal, and no mitotic figures were visible. One tumor had several oncocytic cellular foci revealing cellular transition, with perivascular pseudorosettes consisting of columnar epithelial cells surrounding the fine vasculature. Scattered foci of mammary acinar cell hyperplasia showing oncocytic metaplasia were also observed. Immunohistochemically, the cytoplasm of neoplastic cells of the 2 microtumors showed diffuse immunoreactivity to anti-cytokeratin antibody AE1/AE3, and finely granular immunoreactivity for 60-kDa heat shock protein, mitochondrial membrane ATP synthase complex V beta subunit, and chromogranin A. One tumor also had oncocytic cellular foci forming perivascular pseudorosettes showing cellular membrane immunoreactivity for neural cell adhesion molecule. The tumors were negative for smooth muscle actin, neuron-specific enolase, vimentin, desmin, S100, and synaptophysin. Ultrastructural observation confirmed the abundant mitochondria in the cytoplasm of both neoplastic and hyperplastic cells, the former cells also having neuroendocrine granule-like electron-dense bodies. From these results, our case was diagnosed with mammary oncocytomas accompanied by neuroendocrine differentiation. Scattered foci of mammary oncocytosis might be related to the multicentric occurrence of these oncocytomas.


Asunto(s)
Células Acinares/patología , Adenoma Oxifílico/veterinaria , Enfermedades de los Perros/diagnóstico , Neoplasias Mamarias Animales/diagnóstico , Adenoma Oxifílico/diagnóstico , Adenoma Oxifílico/patología , Animales , Diagnóstico Diferencial , Enfermedades de los Perros/patología , Perros , Femenino , Hiperplasia/diagnóstico , Hiperplasia/patología , Hiperplasia/veterinaria , Neoplasias Mamarias Animales/patología , Vimentina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA